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SUMMARY
In recent years, methicillin-resistant Staphylococcus aureus (MRSA) isolates in
Spain have increased dramatically; in 1986 there were only 1P2% MRSA amongst
all nosocomial Staphylococcus aureus (SA) isolates, by 1989 this percentage had
risen to 44% in some hospital causing a very serious epidemic situation in the
country. We have characterized these isolates by direct, reverse and Fisk phage
typing and we have also looked for an additional local set of phages to help us to
differentiate these strains. We have been able to differentiate an epidemic strain
from other MRSA strains which cause sporadic hospital outbreaks, and we have
also distinguished between some variants of the epidemic strain.
INTRODUCTION
During the past 10 years, methicillin-resistant Staphylococcus aureus (MRSA)
strains had been causing important hospital infections around the world [1]. In
Spain the percentage of MRSA isolates was formerly very low (1 2 %) [2] except
for some local problems [3], but late in 1989 MRSA strains caused important
nosocomial outbreaks in three Spanish hospitals from two regions. During 1990
these MRSA strains spread throughout the country affecting several hospitals [4].
Since then, there has been a constant increase in the epidemic situation; and in
1991-2 MRSA strains were isolated from 31 hospitals from ten different regions.
In this paper we report the results of phage typing 3759 MRSA isolates, the
selection of an additional set of phages extracted from a collection of 115 MRSA
isolates from different hospitals during the 1989-91 period, and the patterns
obtained after applying such phages and ten supplementary phages for MRSA [5]
to a group of 1415 MRSA strains (1376 epidemic and 39 non-epidemic).
MATERIALS AND METHODS
Isolates
A total of 3759 MRSA isolates was received in our laboratory from 31 Spanish
hospitals between October 1989 and December 1992.
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Phage typing
Phage typing was performed by the routine method [6]. Non-typable isolates
were also phage typed after heat treatment [7]. According to the results obtained
with direct phage typing we selected 202 isolates to perform further studies.
Reverse typing
Prophages were induced by mitomycin C [8] from 2639 isolates non-typable by
direct phage typing and from the 202 selected strains and these were matched with
the propagating strains of the International set of S. aureus phages.
Fisk typing (Cross spotting)
Induced supernates from each of all the 202 selected strains were also spot
inoculated onto lawns of all the 202 strains [9].
Antimicrobial susceptibility testing
The 202 isolates were examined using 15 antimicrobial drugs: penicillin,
clarithromycin, clindamycin, rifampicin, fosfomycin, erythromycin, neomycin,
fusidic acid, vancomycin, gentamicin, ciprofloxacin, cloxacillin, methicillin,
bacitracin and mupirocin.
Minimal Inhibitory Concentrations (MICs) were determined by the agar
dilution method [10]. The isolates were assigned to susceptibility in accordance
with NCCLS criteria [11].
Selection of a local set of phages
To get an additional set of local phages, 115 isolates were selected according to
their phage pattern and origin amongst the total number of MRSA isolates
received in our laboratory during the period 1989-91. Prophages were induced
from isolates with mitomycin C and they were spotted onto all parenteral strains.
Eight phages were selected because of their high percentage of lytic capacity and
discriminatory efficacy. These phages were titrated on several strains and the most
sensitive was selected to propagate them. These phages were designated with
numbers from 30 to 38 (except number 36). The source and origin of the lysogenic
and propagating strains are shown in Table 1. They were propagated by the soft
agar overlay method [12] and their lytic spectra were determined (Table 2).
Additional phages
A set of ten supplementary phages for MRSA [5] was kindly sent to our
laboratory by Dr Marples (CPHL, Colindale, London). We propagated them by
the soft agar overlay method [12].
A selection of 1415 MRSA isolates, including isolates from each year of the
study and from all affected hospitals was phage typed with the supplementary and
the local phages for MRSA strains.
RESULTS
By direct phage typing we could differentiate two groups among 3580 epidemic
isolates: one group was lysed at RTD with a large number of group III phages
(6/42E/47/54/75/77/84/85) and the other group was non typable but was typed
after heat treatment with phages from groups I and III (29/77/84) (Table 3).
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Table 1. Origin of lysogenic and propagating MRSA strains and designation of
phages
Lysogenic strains Propagating strains
A A ,s 5 Designation
Number Source Origin Number Source Origin of phages
8361 Blood Madrid 8789 Sputum Granada 30
4114 Wound Sevilla 9302 Sputum Barcelona 31
5715 Wound Sevilla 6594 Blood Madrid 32
8261 Urine Sevilla 543 Unknown Madrid 33
6596 Unknown Madrid 44 Blood Sevilla 34
8762 Skin Granada 48 Catheter Sevilla 35
709 Blood Madrid 4231 Catheter Madrid 37
2504 Blood Madrid 1148 Exudate Madrid 38
Table 2. Lytic spectra of local phages
Phages*
Strain 30 31 32 33 34 35 37 38
29 - 0
52 0 - 0
52A 1 1 3 1 3 1
80 1 4 1 2 1 0 1
2009 0 4 0 0
3A - 1 1 1 1 1
8719 0
42C 0 0 0
42E 0 0
47 5 4 5 5 5 5 5 5
53 0 - 0 2 3 4 4
54 0 4 3 2 3 3 4 4
75 0 0 2 4 0 4 2
77 0 3 4 3 4 4
* , indicates no reaction; 0, indicates inhibition; 1-5, indicates relative strength of reaction.
Table 3. Phage typing ofMRSA i8olates in Spain (1989-92)
Phage-group Number
Year (method) Phage type (percentage)
1989 I-III (HT) 29/77/84 147 (51 8)
III (RTD) 6/42E/47/54/75/77/84/85 113 (48 2)
1990 I-III (HT) 29/77/84 493 (63 1)
III (RTD) 6/42E/47/54/75/77/84/85 288 (369)
1991 I-III (HT)* 29/77/84 614 (793)
III (RTD) 6/42E/47/54/75/77/84/85 109 (144)
I-III (100 RTD) 29/42E/53/83A 51 (66)
1992 I-III (HT) 29/77/84 1385 (71-2)
III (RTD) 6/42E/47/54/75/77/84/85 431 (222)
I-III (100 RTD) 29/42E/53/83A 113 (58)
III (RTD) 47/53/83A/84 15 (0 8)
* HT, Heat treatment.
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NT 979 (71 1) 97 (7)
618/622/626/630 110 (8) 190 (139)
Local MRSA phages
NT 43 (31) 4 (03)
34 59 (4 3) 18 (1 3)
33/34/37/38 293 (213) 27 (2)
30/32/33/34/35/38/38 673 (489) 237 (172)
32 8 (06) 1 (01)
38 13 (0 9)
The distribution of these two groups of strains around the country was
heterogeneous. Figure 1 shows the distribution of these two phage-groups of
epidemic strains during the 1989-92 period in the most affected regions.
There were 179 isolates corresponding to two different outbreaks not related
with the epidemic strains, one typed with phage group I-III (29/42E/53/83A)
and the other was lysed by phages from group III (47/53/83A/84) (Table 3).
Phage typing with additional phages
A selection of 1415 MRSA isolates was studied by applying two sets of
additional phages. The relationship between the patterns obtained with both sets
on the epidemic strains are shown in Table 4.
After applying the MRSA supplementary set at 100 RTD we could distinguish
two groups among the epidemic strains and also we differentiated a group of non-
epidemic strains.
With the nine local phages obtained in our laboratory, we could differentiate
clearly the non-epidemic from the epidemic strains and we also distinguished two
major and two minor groups among the epidemic strains.
The evolution of the majority patterns obtained with the additional phages
among the epidemic strains is shown in Figure 2.
All the epidemic strains tested, including both groups of non-typable and
typable isolates showed a very similar pattern by reverse phage typing. But we
could differentiate clearly the non-epidemic strains.
With the cross spotting (Fisk typing) we could differentiate at least two main
groups among the epidemic strains. Again, the non-epidemic strains were clearly
different.
Antibiotic susceptibility
All epidemic strains of both phage groups were resistant to penicillin (MIC >
32 mg/l), clarithromycin (MIC > 129 mg/l), clindamycin (MIC > 8 mg/l), fosfo-
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Fig. 2. Evolution of the major patterns obtained with additional MRSA phages.
bacitracin (mean MIC 25 mg/i), ciprofloxacin (MIC 16 mg/i), cloxacillin (MIC
128 mg/i) and methicillin (MIC 256 mg/i). Susceptibility to rifampicin was
reduced (MIC 4 mg/i). They were uniformly susceptible to the other non-
betalactam antibiotic tested.
The two non-epidemic strains had different antibiotic susceptibility patterns
between them and with respect to the epidemic strains. One was susceptible to
rifampicin (MIC 0-12 mg/i) and ciprofloxacin (MIC 0-12 mg/i) and the other was
susceptible to clindamycin (mean MIC 0-06 mg/i), rifampicin (MIC 0-12 mg/i) and
ciprofloxacin (MIC 0-5 mg/i).
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DISCUSSION
In recent years the incidence of nosocomial infection due to MRSA has increased
dramatically in many Spanish hospitals all around the country. In a survey of 74
hospitals, methicillin-resistant strains were 1-5% of the total S. aureus [2], in
1990 that percentage has risen to 11-0% [13]. Some hospitals have reported an
incidence of 20-25% of MRSA of S. aureus isolates in their hospitals [14].
By phage typing we have been able to identify and differentiate between
epidemic and sporadic strains involved in hospital outbreaks over the last 4 years.
Also, phage typing has allowed us to analyse the evolution and dissemination of
the strains that initially appeared in Madrid and Seville and further spread to
other Spanish regions [15].
The fact that amongst the epidemic strains we found two different patterns with
very similar epidemic behaviour and the similar patterns obtained by reverse
typing lead us to think of a possible single clonal origin. To answer that question
we performed a deeper study on a selection of isolates, choosing strains from all
the regions and both patterns. After doing the cross-spotting phage typing we
could differentiate several patterns, all of them occurring in both the major phage
typing patterns, which could indicate a divergent evolution of the epidemic strains
[4].
To investigate this problem further we applied a supplementary set of phages
more specific for methicillin-resistant strains which were useful to identify a non-
related outbreak and to differentiate two groups among the epidemic strains.
Again, in both groups there were representative isolates from the two phage
typing patterns. We also looked for additional local phages to increase our
knowledge in relation to the evolution and differentiation of the epidemic isolates.
With these local phages we found four main variants and we could discriminate
the non-epidemic strains. The utility of supplementary phages to distinguish
MRSA strains had been shown in different studies [16, 17] and we think that it
would be useful to use an international supplementary set of phages to analyse the
evolution of MRSA strains.
It further remains to apply molecular markers to complete these studies and to
obtain an extensive characterization of these epidemic strains.
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